May 22, 2024 - AGM & Conference on global trends in research and development

We are pleased to invite you to BIOQuébec's Annual General Meeting 2023, a key event for our members.

The meeting will be followed by a conference and a cocktail reception.

📆 Date: May 22, 2024

🕒 Time: 4 pm to 7:30 pm

📍 Location: Centre PHI, 407 Rue Saint-Pierre, Montreal, QC H2Y 2M3

The conference will focus on global R&D trends and future prospects in healthcare, offered by experts from IQVIA and Deloitte.

Please note that while the Annual General Meeting is reserved for BIOQuébec members in status, the conference and cocktail reception are open to the public. Haven't yet completed your membership? Click here to join.

Program

  • 4:00 to 4:50 pm: Annual General Meeting

  • 5:00 p.m. to 6:00 p.m.: Conference

  • 6:00 p.m. to 7:30 p.m.: Cocktail reception

Deloitte conference: Embracing the Future of Health in Canada through Innovative Partnerships and Paradigm Shits

Geneviève Giguère
Partner - Deloitte

As the partner responsible for our Health Care practice in Quebec and our national Life Sciences practice, Geneviève works with a variety of public and private organizations across Canada to support their digital, operational, and clinical transformations. She is particularly interested in innovative care models, the use of technology to alleviate pressure on the workforce, and ecosystems and partnerships. Previously, she held an executive role in a multinational pharmaceutical organization. Geneviève’s experience across both the health care and pharmaceutical sectors enables her to design and implement large-scale transformations.

 

IQVIA conference : Global R&D trends

Mark Omoto
General Manager, Thought Leadership, Marketing & Communications, Canada - IQVIA

As General Manager at IQVIA Canada, Mark oversees IQVIA’s thought leadership strategy and initiatives, and leads its marketing and corporate communications teams.

He also provides consulting leadership to companies in the pharmaceutical, biotech, and government sectors across IQVIA’s Consulting, Analytics, Market Access, and Technology Solutions.

Mark has held senior roles as President, and Vice President Commercial at several leading pharmaceutical, biotech, technology, and start-up companies.

A business leader with more than 25 years of experience in the pharmaceutical, information technology, and consulting sectors, Mark brings product launch, market access and global marketing expertise across multiple therapeutic areas to his work at IQVIA.

Matthew Laro